Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan. (Q50919131)
Jump to navigation
Jump to search
scientific article published in October 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan. |
scientific article published in October 1997 |
Statements
Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan. (English)
1 reference
J G Edmeads
1 reference
D S Millson
1 reference
1 October 1997
1 reference
1 reference
17 Suppl 18
1 reference
41-52
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference